Burks, S. M., Rosas-Hernandez, H., Alejandro Ramirez-Lee, M., Cuevas, E. & Talpos, J. C. Can SARS-CoV-2 contaminate the main nerve system by means of the olfactory bulb or the blood–brain barrier? Brain Behav. Immun. 95, 7–14 (2021).
Mao, L. et al. Neurologic symptoms of hospitalized clients with coronavirus illness 2019 in Wuhan, China. JAMA Neurol. 77, 683–690 (2020).
Varatharaj, A. et al. Neurological and neuropsychiatric problems of COVID-19 in 153 clients: a UK-wide monitoring research study. Lancet Psychiatry 7, 875–882 (2020).
Moriguchi, T. et al. A very first case of meningitis/encephalitis related to SARS-coronavirus-2. Int. J. Infect. Dis. 94, 55–58 (2020).
Bhalerao, A. et al. In vitro modeling of the neurovascular system: advances in the field. Fluids Barriers CNS 17, 22 (2020).
Oddo, A. et al. Advances in microfluidic blood–brain barrier (BBB) designs. Trends Biotechnol. 37, 1295–1314 (2019).
Michael, B. D. et al. Astrocyte- and neuron-derived CXCL1 drives neutrophil transmigration and blood–brain barrier permeability in viral sleeping sickness. Cell Rep. 32, 108150 (2020).
He, Q. et al. Herpes simplex infection 1-induced blood–brain barrier damage includes apoptosis related to GM130-mediated Golgi tension. Front Mol. Neurosci. 13, 2 (2020).
Cle, M. et al. Zika virus infection promotes regional swelling, cell adhesion particle upregulation, and leukocyte recruitment at the blood–brain barrier. mBio 11, e01183-20 (2020).
Thakur, K.T. et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain 144, 2696–2708 (2021).
Matschke, J. et al. Neuropathology of clients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 19, 919–929 (2020).
Reichard, R. R. et al. Neuropathology of COVID-19: a spectrum of vascular and severe distributed encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 140, 1–6 (2020).
Douaud, G. et al. SARS-CoV-2 is related to modifications in brain structure in UK Biobank. Nature 604, 697–707 (2022).
Krasemann, S. et al. The blood–brain barrier is dysregulated in COVID-19 and works as a CNS entry path for SARS-CoV-2. Stem Cell Rep. 17, 307–320 (2022).
Jiao, L. et al. The olfactory path is a possible method for SARS-CoV-2 to get into the main nerve system of rhesus monkeys. Signal Transduct. Target Ther. 6, 169 (2021).
Song, E. et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 218, e20202135 (2021).
Zhang, L. et al. SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disturbance without tight junctions change. Signal Transduct. Target Ther. 6, 337 (2021).
Yinda, C. K. et al. K18-hACE2 mice establish breathing illness looking like serious COVID-19. PLoS Pathog. 17, e1009195 (2021).
Jiang, R. D. et al. Pathogenesis of SARS-CoV-2 in transgenic mice revealing human angiotensin-converting enzyme 2. Cell 182, 50–58.e58 (2020).
Zhang, B. Z. et al. SARS-CoV-2 contaminates human neural progenitor cells and brain organoids. Cell Res. 30, 928–931 (2020).
Ramani, A. et al. SARS-CoV-2 targets nerve cells of 3D human brain organoids. EMBO J. 39, e106230 (2020).
Bullen, C. K. et al. Infectability of human BrainSphere nerve cells recommends neurotropism of SARS-CoV-2. ALTEX 37, 665–671 (2020).
McMahon, C. L., Staples, H., Gazi, M., Carrion, R. & Hsieh, J. SARS-CoV-2 targets glial cells in human cortical organoids. Stem Cell Rep. 16, 1156–1164 (2021).
Pellegrini, L. et al. SARS-CoV-2 contaminates the brain choroid plexus and interrupts the blood–CSF barrier in human brain organoids. Cell Stem Cell 27, 951–961.e955 (2020).
Jacob, F. et al. Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium. Cell Stem Cell 27, 937–950.e939 (2020).
Bhatia, S. N. & Ingber, D. E. Microfluidic organs-on-chips. Nat. Biotechnol. 32, 760–772 (2014).
Abaci, H. E. & Shuler, M. L. Human-on-a-chip style methods and concepts for physiologically based pharmacokinetics/pharmacodynamics modeling. Integr. Biol. 7, 383–391 (2015).
Huh, D. et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662–1668 (2010).
Vatine, G. D. et al. Human iPSC-derived blood–brain barrier chips make it possible for illness modeling and customized medication applications. Cell Stem Cell 24, 995–1005.e1006 (2019).
Ahn, S. I. et al. Microengineered human blood–brain barrier platform for comprehending nanoparticle transportation systems. Nat. Commun. 11, 175 (2020).
Bhise, N. S. et al. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication 8, 014101 (2016).
Knowlton, S. & Tasoglu, S. A bioprinted liver-on-a-chip for drug screening applications. Trends Biotechnol. 34, 681–682 (2016).
Agarwal, A., Goss, J. A., Cho, A., McCain, M. L. & Parker, K. K. Microfluidic heart on a chip for greater throughput medicinal research studies. Lab Chip 13, 3599–3608 (2013).
Ugolini, G. S., Visone, R., Cruz-Moreira, D., Mainardi, A. & Rasponi, M. Generation of practical heart microtissues in a whipping heart-on-a-chip. Methods Cell. Biol. 146, 69–84 (2018).
Brown, J. A. et al. Metabolic effects of inflammatory disturbance of the blood–brain barrier in an organ-on-chip design of the human neurovascular system. J. Neuroinflammation 13, 306 (2016).
Brown, J. A. et al. Metabolic effects of interleukin-6 obstacle in establishing nerve cells and astroglia. J. Neuroinflammation 11, 183 (2014).
Maoz, B. M. et al. A connected organ-on-chip design of the human neurovascular system exposes the metabolic coupling of endothelial and neuronal cells. Nat. Biotechnol. 36, 865–874 (2018).
Ronaldson-Bouchard, K. et al. A multi-organ chip with grown tissue specific niches connected by vascular circulation. Nat. Biomed. Eng. 6, 351–371 (2022).
Ortega-Prieto, A. M. et al. 3D microfluidic liver cultures as a physiological preclinical tool for liver disease B virus infection. Nat. Commun. 9, 682 (2018).
Wang, J. et al. A virus-induced kidney illness design based upon organ-on-a-chip: pathogenesis expedition of virus-related kidney dysfunctions. Biomaterials 219, 119367 (2019).
Johnson, B. N. et al. 3D printed nerve system on a chip. Lab Chip 16, 1393–1400 (2016).
Junaid, A. et al. Ebola hemorrhagic shock syndrome-on-a-chip. iScience 23, 100765 (2020).
Bai, H. et al. Mechanical control of natural immune actions versus viral infection revealed in a human lung alveolus chip. Nat. Commun. 13, 1928 (2022).
Si, L. et al. A human-airway-on-a-chip for the fast recognition of prospect antiviral rehabs and prophylactics. Nat. Biomed. Eng. 5, 815–829 (2021).
Deinhardt-Emmer, S. et al. SARS-CoV-2 triggers serious epithelial swelling and barrier dysfunction. J. Virol. 95, e00110-21 (2021).
Guo, Y. et al. SARS-CoV-2 caused digestive actions with a biomimetic human gut-on-chip. Sci. Bull. 66, 783–793 (2021).
Thacker, V. V. et al. Rapid endotheliitis and vascular damage define SARS-CoV-2 infection in a human lung-on-chip design. EMBO Rep. 22, e52744 (2021).
Zhang, M. et al. Biomimetic human illness design of SARS-CoV-2 caused lung injury and immune actions on organ chip system. Adv. Sci. 8, 2002928 (2020).
Buzhdygan, T. P. et al. The SARS-CoV-2 spike protein changes barrier function in 2D fixed and 3D microfluidic in-vitro designs of the human blood–brain barrier. Neurobiol. Dis. 146, 105131 (2020).
Sungnak, W. et al. SARS-CoV-2 entry elements are extremely revealed in nasal epithelial cells together with natural immune genes. Nat. Med. 26, 681–687 (2020).
Zou, X. et al. Single-cell RNA-seq information analysis on the receptor ACE2 expression exposes the possible threat of various human organs susceptible to 2019-nCoV infection. Front. Med. 14, 185–192 (2020).
Ballabh, P., Braun, A. & Nedergaard, M. The blood–brain barrier: a summary: structure, guideline, and medical ramifications. Neurobiol. Dis. 16, 1–13 (2004).
Obermeier, B., Daneman, R. & Ransohoff, R. M. Development, upkeep and disturbance of the blood–brain barrier. Nat. Med. 19, 1584–1596 (2013).
Abbott, N. J., Ronnback, L. & Hansson, E. Astrocyte-endothelial interactions at the blood–brain barrier. Nat. Rev. Neurosci. 7, 41–53 (2006).
Bwire, G. M., Majigo, M. V., Njiro, B. J. & Mawazo, A. Detection profile of SARS-CoV-2 utilizing RT-PCR in various kinds of medical specimens: a methodical evaluation and meta-analysis. J. Med. Virol. 93, 719–725 (2021).
Wang, W. et al. Detection of SARS-CoV-2 in various kinds of medical specimens. JAMA 323, 1843–1844 (2020).
Yu, F. et al. Quantitative detection and viral load analysis of SARS-CoV-2 in contaminated clients. Clin. Infect. Dis. 71, 793–798 (2020).
Leng, L. et al. Pathological functions of COVID-19-associated lung injury: an initial proteomics report based upon medical samples. Signal Transduct. Target Ther. 5, 240 (2020).
Walter, L. et al. Nonpsychotropic cannabinoid receptors manage microglial cell migration. J. Neurosci. 23, 1398–1405 (2003).
Liu, Y. J. et al. Late endosomes promote microglia migration by means of cytosolic translocation of immature protease cathD. Sci. Adv. 6, eaba5783 (2020).
Lan, X., Han, X., Li, Q., Yang, Q. W. & Wang, J. Modulators of microglial activation and polarization after intracerebral haemorrhage. Nat. Rev. Neurol. 13, 420–433 (2017).
Orihuela, R., McPherson, C. A. & Harry, G. J. Microglial M1/M2 polarization and metabolic states. Br. J. Pharmacol. 173, 649–665 (2016).
Wang, X. & Khalil, R. A. Matrix metalloproteinases, vascular renovation, and vascular illness. Adv. Pharm. 81, 241–330 (2018).
Raffetto, J. D. & Khalil, R. A. Matrix metalloproteinases and their inhibitors in vascular renovation and vascular illness. Biochem. Pharmacol. 75, 346–359 (2008).
Bocci, M. et al. Infection of brain pericytes underlying neuropathology of COVID-19 clients. Int. J. Mol. Sci. 22, 11622 (2021).
Cardot-Leccia, N., Hubiche, T., Dellamonica, J., Burel-Vandenbos, F. & Passeron, T. Pericyte change clarifies micro-vasculopathy in COVID-19 infection. Intensive Care Med. 46, 1777–1778 (2020).
Sun, J. et al. Transplantation of hPSC-derived pericyte-like cells promotes practical healing in ischemic stroke mice. Nat. Commun. 11, 5196 (2020).
Perrin, P. et al. Cytokine release syndrome-associated encephalopathy in clients with COVID-19. Eur. J. Neurol. 28, 248–258 (2021).
Yang, A. C. et al. Dysregulation of brain and choroid plexus cell enters serious COVID-19. Nature 595, 565–571 (2021).
Ghersi-Egea, J. F. et al. Molecular anatomy and functions of the choroidal blood–cerebrospinal fluid barrier in health and illness. Acta Neuropathol. 135, 337–361 (2018).
Lun, M. P., Monuki, E. S. & Lehtinen, M. K. Development and functions of the choroid plexus-cerebrospinal fluid system. Nat. Rev. Neurosci. 16, 445–457 (2015).
Kumari, P. et al. Neuroinvasion and sleeping sickness following intranasal shot of SARS-CoV-2 in K18-hACE2 mice. Viruses 13, 132 (2021).
Iadecola, C., Anrather, J. & Kamel, H. Effects of COVID-19 on the nerve system. Cell 183, 16–27.e11 (2020).
Chen, L. W. et al. Influenza-associated neurological problems throughout 2014-2017 in Taiwan. Brain Dev. 40, 799–806 (2018).
Radzisauskiene, D., Vitkauskaite, M., Zvinyte, K. & Mameniskiene, R. Neurological problems of pandemic A(H1N1)2009pdm, postpandemic A(H1N1)v, and seasonal influenza A. Brain Behav. 11, e01916 (2021).
Dusedau, H. P. et al. Influenza An infection (H1N1) infection causes microglial activation and temporal dysbalance in glutamatergic synaptic transmission. mBio 12, e0177621 (2021).
Shukla, P., Mandalla, A., Elrick, M. J. & Venkatesan, A. Clinical symptoms and pathogenesis of severe necrotizing encephalopathy: the user interface in between systemic infection and neurologic injury. Front. Neurol. 12, 628811 (2021).
Barbosa-Silva, M. C. et al. Infectious disease-associated encephalopathies. Crit. Care 25, 236 (2021).
Jeanneret, V., Winkel, D., Risman, A., Shi, H. & Gombolay, G. Post-contagious rhombencephalitis after coronavirus-19 infection: a case report and literature evaluation. J. Neuroimmunol. 357, 577623 (2021).
Hara, M. et al. COVID-19 post-infectious sleeping sickness providing with delirium as a preliminary symptom. J. Investig. Med. High Impact Case Rep. 9, 23247096211029787 (2021).
Picollet-D’hahan, N., Zuchowska, A., Lemeunier, I. & Le Gac, S. Multiorgan-on-a-chip: a systemic technique to design and analyze inter-organ interaction. Trends Biotechnol. 39, 788–810 (2021).
Lyu, Z. et al. A neurovascular-unit-on-a-chip for the examination of the corrective capacity of stem cell treatments for ischaemic stroke. Nat. Biomed. Eng. 5, 847–863 (2021).
Chen, S. & Schoen, J. Air-liquid user interface cell culture: from respiratory tract epithelium to the female reproductive system. Reprod. Domest. Anim. 54, 38–45 (2019).
Jiang, D., Schaefer, N. & Chu, H. W. Air-liquid user interface culture of human and mouse respiratory tract epithelial cells. Methods Mol. Biol. 1809, 91–109 (2018).
Topol, E. J. COVID-19 can impact the heart. Science 370, 408–409 (2020).
Lee, I. C., Huo, T. I. & Huang, Y. H. Gastrointestinal and liver symptoms in clients with COVID-19. J. Chin. Med Assoc. 83, 521–523 (2020).
Ertuglu, L. A., Kanbay, A., Afsar, B., Elsurer Afsar, R. & Kanbay, M. COVID-19 and severe kidney injury. Tuberk. Toraks 68, 407–418 (2020).
Wang, P., Wu, Y., Chen, W., Zhang, M. & Qin, J. Malignant melanoma-derived exosomes cause endothelial damage and glial activation on a human BBB chip design. Biosensors 12, 89 (2022).
Chomczynski, P. & Sacchi, N. Single-action technique of RNA seclusion by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159 (1987).
Rowland, R. & Brandariz-Nunez, A. Analysis of the function of N-linked glycosylation in cell surface area expression, function, and binding residential or commercial properties of SARS-CoV-2 receptor ACE2. Microbiol. Spectr. 9, e0119921 (2021).
